What is CyberMDX?
Founded in 2016 and headquartered in New York, CyberMDX is a specialized cybersecurity firm focused on the healthcare technology landscape. The company's core mission is to identify, categorize, and protect connected medical devices, thereby ensuring operational resiliency, patient safety, and the privacy of sensitive data. This focus positions CyberMDX as a critical player in addressing the unique security challenges within the medical device ecosystem.
How much funding has CyberMDX raised?
CyberMDX has raised a total of $30M across 2 funding rounds:
Series A
$10M
Other Financing Round
$20M
Series A (2018): $10M, investors not publicly disclosed
Other Financing Round (2020): $20M led by Relyens Group, Pitango Venture Capita, and Qure Ventures
Key Investors in CyberMDX
Relyens Group
Relyens Group is likely a financial institution or insurance provider with a focus on risk management and healthcare sector investments.
Pitango Venture Capital
Pitango Venture Capital is a prominent venture capital firm known for investing in technology and innovation across various sectors, including cybersecurity.
Qure Ventures
Qure Ventures is presumed to be a venture capital firm specializing in investments within the health-tech and digital health sectors.
What's next for CyberMDX?
The recent major strategic investment signals a pivotal growth phase for CyberMDX. This capital infusion is expected to fuel further development of its advanced threat detection and mitigation solutions for medical devices. The company is likely to expand its market reach, enhance its technological capabilities, and solidify its position as a leader in healthcare cybersecurity, addressing the increasing demand for robust data protection in the medical field.
See full CyberMDX company page
